NEKTAR THERAPEUTICS
Industry: Life Sciences ・ $NKTR on Nasdaq
Insider Sale
+$7,863
-3.1%
Shares
Shares Volume: 7,785 Shares
Average Share Price: $1.01
INSIDER
Zalevsky Jonathan
Chief R&D Officer (Officer)
reported on Nov 20 2024
traded on Nov 19 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 243,019 |
| PURCHASES/SALES 1Y | 0 / 5 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $8,075.73 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 0 / 17 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $16,752.7 |
| COMPANY PREVIOUS TRADES |